Register for "Doing Business With India: Latest Developments in Pharmaceutical Regulation" Webinar, June 27, 11 a.m. – 1 p.m. EDT
FDLI SmartBrief | Jun 09, 2014
India is currently the third-largest producer, by volume, of pharmaceutical products in the world. With such a substantial grasp on the world's market, pharmaceutical stakeholders around the globe need to understand the issues involved in doing business with India. During this webinar, experts will discuss key economic, political and cultural considerations; summarize India's system of drug regulation and the U.S. FDA perspective on these regulations; explore clinical trials and intellectual property issues; and give valuable insights and advice on working with India-based drug manufacturers. View the speakers and register!
No comments:
Post a Comment